Roche Launches First Two NAVIFY Clinical Decision Support Apps
Basel Switzerland – Roche (September 18, 2018) –
(RTTNews) – Swiss drug major Roche Group (RHHBY) announced Tuesday the launch of the first two NAVIFY clinical decision support apps: The NAVIFY Clinical Trial Match and NAVIFY Publication Search apps.
The two apps available on the NAVIFY Tumor Board facilitates oncology care teams access relevant clinical trial information and related publications more effectively.
NAVIFY Clinical Trial Match app identifies clinical trial options based on patient-specific attributes such as age, gender, biomarkers and various tumour information from 11 international registries.
NAVIFY Publication Search app mines publication sources globally for most recent clinically and therapeutically relevant literature.
The content of both apps is provided by MolecularMatch, Inc., a clinical informatics company with expertise in precision oncology, immunotherapy and bioinformatics.
According to the firm, the launch of these first two apps is the start of the NAVIFY apps ecosystem. More apps from Roche, partners and third parties will follow to expand the clinical decision support functionalities.
(RTTNews) – Swiss drug major Roche Group (RHHBY) announced Tuesday the launch of the first two NAVIFY clinical decision support apps: The NAVIFY Clinical Trial Match and NAVIFY Publication Search apps.
The two apps available on the NAVIFY Tumor Board facilitates oncology care teams access relevant clinical trial information and related publications more effectively.
NAVIFY Clinical Trial Match app identifies clinical trial options based on patient-specific attributes such as age, gender, biomarkers and various tumour information from 11 international registries.
NAVIFY Publication Search app mines publication sources globally for most recent clinically and therapeutically relevant literature.
The content of both apps is provided by MolecularMatch, Inc., a clinical informatics company with expertise in precision oncology, immunotherapy and bioinformatics.
According to the firm, the launch of these first two apps is the start of the NAVIFY apps ecosystem. More apps from Roche, partners and third parties will follow to expand the clinical decision support functionalities.